David A. Eagle, MD, New York Cancer & Blood Specialists, discusses the present state of treatment for cancer, which often sees patient financial concerns outweighed by the cost of treatment.
David A. Eagle, MD, chair of legislative affairs and patient advocacy at New York Cancer & Blood Specialists, discusses the present state of treatment for cancer, which often sees patient financial concerns outweighed by the cost of treatment. In this interview from our recent Institute for Value-Based Medicine® meeting in New York City on February 8, he addresses potential legislative focus areas to make inroads in this conflict.
Transcript
Can you discuss some of the top legislative priorities that aim to avoid patient financial toxicity but that still consider payer needs and priorities?
I think that’s the heart of the question in modern oncology. We’re in the middle of this tension. We have just enormous advancing scientific progress, but that’s creating enormous financial pressures on the systems. Cancer patients want the best treatment that they can get, and they deserve that. We have an insurance system, unfortunately, that is built around a permanent care model of cost sharing, which just doesn’t work that well with modern oncology. There really aren’t a lot of substitute products, sometimes, for patients.
I think the other important question moving forward, in addition to the finances, is: Who makes the clinical decisions for the patients? I think, as the oncologists, we want to make those decisions for the patients. We know the patients, we kind of know their personal situation, but more and more I think it’s getting harder and harder for us to make sure we have all the clinical authority over what happens to the patients as well.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Challenges in developing next-generation cancer therapies persist; research indicates widespread utilization and hurdles in affordability and access to glucagon-like peptide-1 (GLP-1) medications; legislation seeks to legalize therapeutic use of psychedelics in California.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Health Equity and Access Weekly Roundup: May 11, 2024
May 11th 2024This week's topics include frameworks for improving health equity nationwide, addressing social determinants of health, discussing CMS's Medicare rules, investigating breast cancer treatment refusal, and exploring HIV and major depressive disorder in underrepresented groups.
Read More